International Journal of Drug Delivery Technology
Volume 15, Issue 2

Antimicrobial Resistance (AMR) to Antibiotic Therapy: An Emerging Healthcare Crisis for Treating Infective Diseases

Ashwini M Bhurre1*, Pratibha Dawaande2, Anita Wanjari3

1Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research , deemed to be University, Sawangi (M) ,Wardha,442001, India

2Datta Meghe Medical College, DMIHER (DU) Wanadongari, Hingna, Nagpur, 441110, India

3Mahatma Gandhi Ayurved College Hospital and Research Centre, DMIHER (DU), Salod(H), Wardha, 442001, India

Received: 19th Mar, 2025; Revised: 1st May, 2025; Accepted: 22nd May, 2025; Available Online: 25th Jun, 2025 

ABSTRACT

The worldwide healthcare system is facing an increasing danger from antimicrobial resistance (AMR), which is influencing antibiotic treatments and driving up healthcare expenditures. Examining the causes, progression, and mechanisms of resistance, the research highlights the need for innovative treatments, novel antibiotics, infection prevention, stewardship initiatives, and global monitoring. In order to combat AMR and guarantee the efficacy of antibiotics, cooperation between governmental bodies, healthcare providers, and academic institutions is essential.

Keywords: antimicrobial resistance, antibiotic therapy, healthcare crisis, antibiotic efficacy.

How to cite this article: Ashwini M Bhurre, Pratibha Dawaande, Anita Wanjari. Antimicrobial Resistance (AMR) to Antibiotic Therapy: An Emerging Healthcare Crisis for Treating Infective Diseases. International Journal of Drug Delivery Technology. 2025;15(2): 855-66. doi:10.25258/ijddt.15.2.62

REFERENCES

  1. Nabi IG, Khan M, Mubeen H. Antimicrobial Resistance: Challenges and Innovative Solutions. New Emirates Medical Journal. 2025 Feb 3:e02506882352704.
  2. Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance & Infection Control. 2018 Dec;7:1-7.
  3. Kumar SG, Adithan C, Harish BN, Sujatha S, Roy G, Malini A. Antimicrobial resistance in India: A review. Journal of natural science, biology, and medicine. 2013 Jul;4(2):286.
  4. Karp BE, Tate H, Plumblee JR, Dessai U, Whichard JM, Thacker EL, Hale KR, Wilson W, Friedman CR, Griffin PM, McDermott PF. National antimicrobial resistance monitoring system: two decades of advancing public health through integrated surveillance of antimicrobial resistance. Foodborne pathogens and disease. 2017 Oct 1;14(10):545-57.
  5. Parveen S, Garzon-Orjuela N, Amin D, McHugh P, Vellinga A. Public health interventions to improve antimicrobial resistance awareness and behavioural change associated with antimicrobial use: a systematic review exploring the use of social media. Antibiotics. 2022 May 16;11(5):669.
  6. Uddin TM, Chakraborty AJ, Khusro A, Zidan BR, Mitra S, Emran TB, Dhama K, Ripon MK, Gajdács M, Sahibzada MU, Hossain MJ. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. Journal of infection and public health. 2021 Dec 1;14(12):1750-66.
  7. Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MA. Antimicrobial resistance: a growing serious threat for global public health. InHealthcare 2023 Jul 5 (Vol. 11, No. 13, p. 1946). MDPI.
  8. Helmy YA, Taha-Abdelaziz K, Hawwas HA, Ghosh S, AlKafaas SS, Moawad MM, Saied EM, Kassem II, Mawad AM. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics. 2023 Jan 30;12(2):274.
  9. Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016 Jan 21;529(7586):336-43.
  10. Jiang T, Chen XS. Outcome impacts due to pathogen-specific antimicrobial resistance: A narrative review of published literature. International Journal of Environmental Research and Public Health. 2020 Feb;17(4):1395.
  11. Komolafe OO. Antibiotic resistance in bacteria-an emerging public health problem. Malawi medical journal. 2003;15(2):63-7.
  12. Berhe DF, Beyene GT, Seyoum B, Gebre M, Haile K, Tsegaye M, Boltena MT, Tesema E, Kibret TC, Biru M, Siraj DS. Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review. Antimicrobial Resistance & Infection Control. 2021 Dec;10:1-4.
  13. Farooq U, Mahajan RC. Drug resistance in malaria. Journal of vector borne diseases. 2004 Dec;41(3/4):45.
  14. Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 2017 Aug;284(16):2569-2578. doi: 10.1111/febs.14127. Epub 2017 Jun 30. PMID: 28580606; PMCID: PMC5575457.
  15. Lee AS, De Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. Methicillin-resistant Staphylococcus aureus. Nature reviews Disease primers. 2018 May 31;4(1):1-23.
  16. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997 Jan;24Suppl 1:S106-9. doi: 10.1093/clinids/24.supplement_1.s106. PMID: 8994789.
  17. Millard J, Ugarte-Gil C, Moore DA. Multidrug resistant tuberculosis. Bmj. 2015 Feb 26;350.
  18. Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE. Hospital-acquired pneumonia in ICU. Anaesthesia Critical Care & Pain Medicine. 2018 Feb 1;37(1):83-98.
  19. Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug‐resistant Plasmodium falciparum malaria. The FEBS journal. 2017 Aug;284(16):2569-78.
  20. Ocan M, Akena D, Nsobya S, Kamya MR, Senono R, Kinengyere AA, Obuku EA. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malaria journal. 2019 Dec;18(1):1-5.
  21. Cui L, Mharakurwa S, Ndiaye D, Rathod PK, Rosenthal PJ. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. The American journal of tropical medicine and hygiene. 2015 Sep 9;93(3 Suppl):57.
  22. Çapcı A, Lorion MM, Wang H, Simon N, Leidenberger M, Borges Silva MC, Moreira DR, Zhu Y, Meng Y, Chen JY, Lee YM. Artemisinin–(Iso) quinoline Hybrids by C− H Activation and Click Chemistry: Combating Multidrug‐Resistant Malaria. AngewandteChemie International Edition. 2019 Sep 9;58(37):13066-79.
  23. Price RN, Von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet infectious diseases. 2014 Oct 1;14(10):982-91.
  24. Hamilton WL, Amato R, van der Pluijm RW, Jacob CG, Quang HH, Thuy-Nhien NT, Hien TT, Hongvanthong B, Chindavongsa K, Mayxay M, Huy R. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. The Lancet Infectious Diseases. 2019 Sep 1;19(9):943-51.
  25. Newby G, Hwang J, Koita K, Chen I, Greenwood B, Von Seidlein L, Shanks GD, Slutsker L, Kachur SP, Wegbreit J, Ippolito MM. Review of mass drug administration for malaria and its operational challenges. The American journal of tropical medicine and hygiene. 2015 Jul 7;93(1):125.
  26. Manyando C, Njunju EM, D’Alessandro U, Van Geertruyden JP. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLos one. 2013 Feb 22;8(2):e56916.
  27. Wicht KJ, Mok S, Fidock DA. Molecular mechanisms of drug resistance in Plasmodium falciparum malaria. Annual review of microbiology. 2020 Sep 8;74:431-54.
  28. Visser BJ, Wieten RW, Kroon D, Nagel IM, Bélard S, van Vugt M, Grobusch MP. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malaria journal. 2014 Dec;13(1):1-8.
  29. Dadashi M, Hajikhani B, Darban-Sarokhalil D, van Belkum A, Goudarzi M. Mupirocin resistance in Staphylococcus aureus: A systematic review and meta-analysis. Journal of global antimicrobial resistance. 2020 Mar 1;20:238-47.
  30. Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future. Clinical infectious diseases. 2014 Jan 1;58(suppl_1):S20-7.
  31. Gajdács M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics. 2019 May 2;8(2):52.
  32. Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Frontiers in microbiology. 2015 Apr 30;6:348.
  33. Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clinical microbiology reviews. 2018 Oct;31(4):10-128.
  34. Grema HA, Geidam YA, Gadzama GB, Ameh JA, Suleiman A. Methicillin resistant Staphylococcus aureus (MRSA): a review. Adv Anim Vet Sci. 2015;3(2):79-98.
  35. Aires-de-Sousa M. Methicillin-resistant Staphylococcus aureus among animals: current overview. Clinical Microbiology and Infection. 2017 Jun 1;23(6):373-80.
  36. Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L. Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update. Canadian Family Physician. 2017 Jul 1;63(7):512-20.
  37. Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review. BMC infectious diseases. 2014 Dec;14(1):1-3.
  38. Wong JW, Ip M, Tang A, Wei VW, Wong SY, Riley S, Read JM, Kwok KO. Prevalence and risk factors of community-associated methicillin-resistant Staphylococcus aureus carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis. Clinical Epidemiology. 2018 Oct 12:1489-501.
  39. Tack B, Vanaenrode J, Verbakel JY, Toelen J, Jacobs J. Invasive non-typhoidal Salmonella infections in sub-Saharan Africa: a systematic review on antimicrobial resistance and treatment. BMC medicine. 2020 Dec;18:1-22.
  40. Britto CD, Wong VK, Dougan G, Pollard AJ. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS neglected tropical diseases. 2018 Oct 11;12(10):e0006779.
  41. Eng SK, Pusparajah P, Ab Mutalib NS, Ser HL, Chan KG, Lee LH. Salmonella: a review on pathogenesis, epidemiology and antibiotic resistance. Frontiers in Life Science. 2015 Jul 3;8(3):284-93.
  42. Jajere SM. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Veterinary world. 2019;12(4):504.
  43. Tadesse G, Tessema TS, Beyene G, Aseffa A. Molecular epidemiology of fluoroquinolone resistant Salmonella in Africa: A systematic review and meta-analysis. PLoS One. 2018 Feb 12;13(2):e0192575.
  44. Akinyemi KO, Ajoseh SO, Fakorede CO. A systemic review of literatures on human Salmonella enterica serovars in Nigeria (1999-2018). The Journal of Infection in Developing Countries. 2021 Sep 30;15(09):1222-35.
  45. Browne AJ, Kashef Hamadani BH, Kumaran EA, Rao P, Longbottom J, Harriss E, Moore CE, Dunachie S, Basnyat B, Baker S, Lopez AD. Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis. BMC medicine. 2020 Dec;18:1-22.
  46. Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015 Jun 19;33:C21-9.
  47. Leopold SJ, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. Journal of Antimicrobial Chemotherapy. 2014 Sep 1;69(9):2337-53.
  48. Tadesse G. A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia. BMC Pharmacology and Toxicology. 2014 Dec;15(1):1-9.
  49. Bastos ML, Lan Z, Menzies D. An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. European Respiratory Journal. 2017 Mar 1;49(3).
  50. Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MH, Ahmed S, Hawlader DH, Hossain A. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC infectious diseases. 2021 Dec;21(1):1-3.
  51. Marks SM, Mase SR, Morris SB. Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis. Clinical Infectious Diseases. 2017 Jun 15;64(12):1670-7.
  52. Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Tropical diseases, travel medicine and vaccines. 2018 Dec;4:1-2.
  53. Asgedom SW, Teweldemedhin M, Gebreyesus H. Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: a systematic review. Journal of pathogens. 2018 Apr 3;2018.
  54. Eshetie S, Gizachew M, Dagnew M, Kumera G, Woldie H, Ambaw F, Tessema B, Moges F. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC infectious diseases. 2017 Dec;17:1-2.
  55. Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Systematic reviews. 2018 Dec;7:1-3.
  56. Agyeman AA, Ofori-Asenso R. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis. Annals of clinical microbiology and antimicrobials. 2016 Dec;15:1-7.
  57. Nellums LB, Rustage K, Hargreaves S, Friedland JS. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis. BMC medicine. 2018 Dec;16(1):1-1.
  58. Harris RC, Khan MS, Martin LJ, Allen V, Moore DA, Fielding K, Grandjean L. The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis. BMC infectious diseases. 2016 Dec;16(1):1-5.
  59. Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, So TM, Yasin RM, Hsueh PR, Carlos CC, Hsu LY. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. American journal of respiratory and critical care medicine. 2011 Dec 15;184(12):1409-17.
  60. Mukhopadhyay C, Bhargava A, Ayyagari A. Role of mechanical ventilation & development of multidrug resistant organisms in hospital acquired pneumonia. Indian Journal of Medical Research. 2003 Dec 1;118:229-35.
  61. Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratala J. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clinical microbiology and infection. 2011 Nov 1;17(11):1659-65.
  62. Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, Pesci A, Blasi F, Torres A. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013 Nov 1;68(11):997-9.
  63. Werarak P, Kiratisin P, Thamlikitkul V. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. J Med Assoc Thai. 2010 Jan 1;93(Suppl 1):S126-38.
  64. Joseph NM, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. The Journal of Infection in Developing Countries. 2010 Jan 18;4(04):218-25.
  65. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. American journal of respiratory and critical care medicine. 2013 Oct 15;188(8):985-95.
  66. Dey A, Bairy I. Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: A nine months' prospective study. Annals of thoracic medicine. 2007 Apr 1;2(2):52-7.
  67. Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics. 2020 Apr 20;9(4):196.
  68. Majumder MA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, Gittens-St Hilaire M. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infection and drug resistance. 2020 Dec 29:4713-38.
  69. Gajdács M, Urbán E, Stájer A, Baráth Z. Antimicrobial resistance in the context of the sustainable development goals: A brief review. European Journal of Investigation in Health, Psychology and Education. 2021 Jan 19;11(1):71-82.
  70. Radhouani H, Silva N, Poeta P, Torres C, Correia S, Igrejas G. Potential impact of antimicrobial resistance in wildlife, environment and human health. Frontiers in microbiology. 2014 Feb 5;5:23.